Eva
González-Haba Peña
Eva González-Haba Peña-rekin lankidetzan egindako argitalpenak (1)
2018
-
Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/ HER2– advanced or metastatic breast cancer in Spain
ClinicoEconomics and Outcomes Research, Vol. 10, pp. 773-790